Rock Springs Capital Management LP Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$1.4B
Holdings
136
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (136 positions)
| Stock | Value |
|---|---|
—AETNA INC NEW | $53.7M |
ACHCACADIA HEALTHCARE COMPANY IN | $46.4M |
—TESARO INC | $43.7M |
—ALLERGAN PLC | $41.9M |
PFEPFIZER INC | $37.2M |
HCAHCA HOLDINGS INC | $33.1M |
—RADIUS HEALTH INC | $31.9M |
—SPARK THERAPEUTICS INC | $31.2M |
ISRGINTUITIVE SURGICAL INC | $29.1M |
GILDGILEAD SCIENCES INC | $28.7M |
—ADVANCED ACCELERATOR APPLIC | $27.8M |
ALXNALEXION PHARMACEUTICALS INC | $27.5M |
CICIGNA CORPORATION | $26.5M |
WCGEURWELLCARE HEALTH PLANS INC | $25.2M |
CELGCELGENE CORP | $25.1M |
—GW PHARMACEUTICALS PLC | $24.7M |
—MEDICINES CO | $22.9M |
—SHIRE PLC | $22.1M |
LLYLILLY ELI & CO | $21.7M |
TEVATEVA PHARMACEUTICAL INDS LTD | $19.8M |
NBIXNEUROCRINE BIOSCIENCES INC | $18.6M |
ACRSACLARIS THERAPEUTICS INC | $18.5M |
—HEARTWARE INTL INC | $18.0M |
PCRXPACIRA PHARMACEUTICALS INC | $15.9M |
TBPHTHERAVANCE BIOPHARMA INC | $15.9M |
TMOTHERMO FISHER SCIENTIFIC INC | $14.8M |
MCKMCKESSON CORP | $14.5M |
BMYBRISTOL MYERS SQUIBB CO | $14.5M |
PENPENUMBRA INC | $14.4M |
JAZZJAZZ PHARMACEUTICALS PLC | $14.4M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $14.4M |
AMGNAMGEN INC | $14.3M |
MDMEDNAX INC | $14.1M |
BIIBBIOGEN INC | $13.9M |
—THERAPEUTICSMD INC | $13.4M |
WBAWALGREENS BOOTS ALLIANCE INC | $13.4M |
INCYINCYTE CORP | $12.4M |
GLPGGALAPAGOS NV | $11.6M |
ARDXARDELYX INC | $11.1M |
PRTAPROTHENA CORP PLC | $10.8M |
PRAHPRA HEALTH SCIENCES INC | $10.6M |
—DERMIRA INC | $10.4M |
—HEALTHSOUTH CORP | $10.3M |
—ACHILLION PHARMACEUTICALS IN | $10.2M |
—WRIGHT MED GROUP N V | $9.5M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $9.5M |
—RETROPHIN INC | $9.3M |
BMRNBIOMARIN PHARMACEUTICAL INC | $8.8M |
—XENOPORT INC | $8.4M |
ALKSALKERMES PLC | $8.4M |
EWEDWARDS LIFESCIENCES CORP | $8.3M |
HOLXHOLOGIC INC | $8.0M |
MCRB1EURSERES THERAPEUTICS INC | $7.6M |
—JUNO THERAPEUTICS INC | $7.6M |
—ENVISION HEALTHCARE HLDGS IN | $7.4M |
ITCIEURINTRA CELLULAR THERAPIES INC | $7.4M |
VRTXVERTEX PHARMACEUTICALS INC | $7.4M |
—OPHTHOTECH CORP | $7.3M |
—AMERICAN RENAL ASSOCIATES HO | $7.2M |
—CORSICANTO LTD | $7.2M |
RAREULTRAGENYX PHARMACEUTICAL IN | $6.9M |
CHRSCOHERUS BIOSCIENCES INC | $6.8M |
ONCBEIGENE LTD | $6.7M |
—RTI SURGICAL INC | $6.7M |
CRVSCORVUS PHARMACEUTICALS INC | $6.4M |
NVTA1EURINVITAE CORP | $6.3M |
—FIVE PRIME THERAPEUTICS INC | $6.3M |
—ATHENAHEALTH INC | $6.3M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $6.2M |
NVAXNOVAVAX INC | $6.2M |
—CARDIOME PHARMA CORP | $6.1M |
—EPIZYME INC | $6.1M |
MGNXMACROGENICS INC | $6.1M |
HRCHILL ROM HLDGS INC | $6.1M |
REGNREGENERON PHARMACEUTICALS | $5.9M |
—EGALET CORP | $5.9M |
—PARATEK PHARMACEUTICALS INC | $5.8M |
—NOVADAQ TECHNOLOGIES INC | $5.5M |
—AVEXIS INC | $5.4M |
CGENCOMPUGEN LTD | $5.3M |
—CHINA CORD BLOOD CORP | $5.1M |
—PROTEOSTASIS THERAPEUTICS IN | $5.0M |
IM8NINSMED INC | $4.9M |
INSYEURINSYS THERAPEUTICS INC NEW | $4.7M |
—ADURO BIOTECH INC | $4.7M |
—ALDER BIOPHARMACEUTICALS INC | $4.5M |
—TANDEM DIABETES CARE INC | $4.5M |
—INTERSECT ENT INC | $4.4M |
—ALLERGAN PLC | $4.2M |
—PORTOLA PHARMACEUTICALS INC | $4.1M |
—KITE PHARMA INC | $4.0M |
ASNDASCENDIS PHARMA A S | $4.0M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $3.9M |
OTICEUROTONOMY INC | $3.8M |
AM6AMICUS THERAPEUTICS INC | $3.7M |
FGENEURFIBROGEN INC | $3.7M |
—AURIS MED HLDG AG | $3.6M |
—MEDICINES CO | $3.5M |
INVAINNOVIVA INC | $3.5M |
—ENDOCHOICE HLDGS INC | $3.5M |
Page 1 of 2Next